Inhaling a vaporized liquid solution through an e-cigarette, otherwise known as vaping, immediately impacts vascular function even when the solution does not include nicotine, according to the results of a new study published in Radiology.

Jackson Memorial Hospital in Miami celebrated the opening of two newly renovated cardiac catheterization suites during a ribbon-cutting ceremony on August 19, 2019. The suites feature the new Alphenix Core+ from Canon Medical Systems, which provides diverse imaging without compromising image quality or performance. Jackson Memorial is the first hospital in Florida offering this new technology.

Physicians at the Froedtert & the Medical College of Wisconsin (MCW) Clinical Cancer Center in Milwaukee have treated the first cancer patient in the world using Accuray’s Radixact System with Synchrony motion tracking and correction technology. The patient was a 45-year-old man with lung cancer. With the addition of Synchrony, the Radixact System was able to track the lung tumor in real time as it moved with the patient's breathing and automatically adjust the radiation beam to keep it targeted on the tumor. This enabled the clinical team to deliver the maximum dose of radiation they felt necessary to destroy cancer cells, while minimizing the risk of damage to surrounding healthy tissues. The Radixact and CyberKnife systems both feature the Synchrony automated motion tracking and correction functionality.

Healthcare data breaches are currently being reported at a rate of more than one a day, according to a new report from the nonprofit Institute for Healthcare IT (IHIT). And for those who think it can’t happen to them, the odds are not in their favor. Breaches reported between 2009 and 2018 have resulted in the theft or exposure of almost 190 million healthcare records, a number equal to 59 percent of the U.S. population, according to the HIPAA Journal.

Boston Scientific Corp. announced the completion of its acquisition of BTG plc. pursuant to the previously announced scheme of arrangement. BTG develops and commercializes products used in minimally invasive procedures targeting cancer and vascular diseases, as well as specialty pharmaceuticals.

HonorHealth Scottsdale Osborn Medical Center is the first hospital in Arizona to begin offering GammaTile Therapy, a new approach to treating recurrent brain tumors. GammaTile Therapy is a U.S. Food and Drug Administration (FDA)-cleared, surgically targeted radiation therapy (STaRT) that is designed to delay tumor regrowth for patients with all types of recurrent brain tumors. The first patient was treated by John Wanebo, M.D., a neurosurgeon and an independent member of the HonorHealth medical staff.

An international team of researchers developed a new magnetic resonance imaging (MRI) technique that can capture an image of a brain thinking by measuring changes in tissue stiffness. The results show that brain function can be tracked on a time scale of 100 milliseconds – 60 times faster than previous methods. The technique could shed new light on altered neuronal activity in brain diseases.

A drug used to treat attention-deficit/hyperactivity disorder (ADHD) appears to affect development of the brain’s signal-carrying white matter in children with the disorder, according to a study published in the journal Radiology.1 The same effects were not found in adults with ADHD.